ADBIOTECH Announces 3 Billion KRW Convertible Bond Issue... Potential Dilution of 37.44% Including Existing CBs
ADBIOTECH will issue 3 billion KRW in Series 10 unregistered private convertible bonds to BKP Investment Fund 1. The payment date has been postponed from June 5, 2026 to August 31, 2026, and the conversion price lowered from 2,678 KRW to 2,495 KRW, increasing dilution concerns for existing shareholders.
The new issuance will add 1,202,404 shares, representing 5.76% of outstanding shares. Combined with existing outstanding convertible bonds totaling 11.25 billion KRW, the potential dilution ratio reaches 37.44%.
The funds are intended for acquisition of securities in other corporations, though the specific target remains undetermined. The acquirer, BKP Investment Fund 1, is solely funded by ETRON, whose auditor issued a disclaimer of opinion, raising governance concerns.
ADBIOTECH has not disclosed any share buyback, cancellation, or dividend policy, leaving shareholder return measures absent.
[AI Summary]This convertible bond issuance imposes a 5.76% dilution on existing shareholders, and together with prior CBs, cumulative dilution hits 37.44%, pressuring the stock price. Uncertainty over fund usage and counterparty financial health warrants investor caution.
KOSDAQ Filing Information
[Correction of Description] Report on Major Matters (Decision on Issuance of Convertible Bonds)